INQ000408453 – Press release from the Medicines and Healthcare products Regulatory Agency titled MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, dated 07/04/2021.

  • 发表： 22 2025年1月
  • 引证： 2025 年 1 月 22 日, 2025 年 1 月 22 日
  • 类型： 证据
  • 模块： 模块 4

Press release from the Medicines and Healthcare products Regulatory Agency titled MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, dated 07/04/2021.

模块 4 引述：
 • 2025 年 1 月 22 日第 1、4 页

下载此文档